GGrantIndex
← Leaderboards

Becky Lynn Genberg

Johns Hopkins University

$7,758,629
Attributed
$11,412,427
Total exposure
7
Grants
4
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $3.8M · FY200825
$5M$3.8M$2.5M$1.3M$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$10,362,430 · 6
CDC$1,049,997 · 1

By mechanism

R01$10,035,468 · 4
K01$826,371 · 1
R21$450,313 · 1
R36$100,275 · 1

Top collaborators

Most similar at Johns Hopkins University

Same institution · by research overlap

Others in their field

Top investigators on “Communities

Research focus

CommunitiesServicesEconomicsHealth Services AccessibilityMortalityAntiretroviral TherapyCaringRuralTherapy DesignInterviewBaseResourcesLinkPreventSocialPersonsAids PreventionAffectPoliciesTransmission ProcessCohortPreventionUnited States National Institutes Of HealthInjecting Drug User

Grant awards (25)

The short and long-term dynamics of opioid/stimulant use: Mixed methods to inform overdose prevention and treatment related to polysubstance use$730,458
R01 · FY2025 · DA · contact PI
When pandemics collide: The intersection of the opioid crisis, COVID-19 and HIV pandemics among people who inject drugs in the United States$394,272
R01 · FY2024 · DA · contact PI
RFA-CE-22-011: Mixed methods study of polysubstance use to optimize overdose prevention$349,999
R01 · FY2024 · CE
Rapid Research for Xylazine Response$122,813
R21 · FY2024 · DA
When pandemics collide: The intersection of the opioid crisis, COVID-19 and HIV pandemics among people who inject drugs in the United States$691,854
R01 · FY2023 · DA · contact PI
Harambee: Integrated Community-Based HIV/NCD Care & Microfinance Groups in Kenya$506,812
R01 · FY2023 · MH
Mixed methods study of polysubstance use to optimize overdose prevention$349,999
R01 · FY2023 · CE
Rapid Research for Xylazine Response$327,500
R21 · FY2023 · DA
The short and long-term dynamics of opioid/stimulant use: Mixed methods to informoverdose prevention and treatment related to polysubstance use$162,694
R01 · FY2023 · DA · contact PI
The short and long-term dynamics of opioid/stimulant use: Mixed methods to informoverdose prevention and treatment related to polysubstance use$2,158,107
R01 · FY2022 · DA · contact PI
When pandemics collide: The intersection of the opioid crisis, COVID-19 and HIV pandemics among people who inject drugs in the United States$788,893
R01 · FY2022 · DA · contact PI
Harambee: Integrated Community-Based HIV/NCD Care & Microfinance Groups in Kenya$533,750
R01 · FY2022 · MH
Mixed methods study of polysubstance use to optimize overdose prevention$349,999
R01 · FY2022 · CE
When pandemics collide: The intersection of the opioid crisis, COVID-19 and HIV pandemics among people who inject drugs in the United States$637,354
R01 · FY2021 · DA · contact PI
Harambee: Integrated Community-Based HIV/NCD Care & Microfinance Groups in Kenya$541,608
R01 · FY2021 · MH
When pandemics collide: The intersection of the opioid crisis, COVID-19 and HIV pandemics among people who inject drugs in the United States$665,811
R01 · FY2020 · DA · contact PI
Harambee: Integrated Community-Based HIV/NCD Care & Microfinance Groups in Kenya$556,494
R01 · FY2020 · MH
Harambee: Integrated Community-Based HIV/NCD Care & Microfinance Groups in Kenya$617,364
R01 · FY2019 · MH
Linkage to Care Following Home-Based Counseling and Testing in Western Kenya$165,271
K01 · FY2017 · MH · contact PI
Linkage to Care Following Home-Based Counseling and Testing in Western Kenya$164,518
K01 · FY2016 · MH · contact PI
Linkage to Care Following Home-Based Counseling and Testing in Western Kenya$164,813
K01 · FY2015 · MH · contact PI
Linkage to Care Following Home-Based Counseling and Testing in Western Kenya$164,739
K01 · FY2014 · MH · contact PI
Linkage to Care Following Home-Based Counseling and Testing in Western Kenya$167,030
K01 · FY2013 · MH · contact PI
Long Term Injection Cessation among Injection Drug Users (IDUs)$48,547
R36 · FY2009 · DA · contact PI
Long Term Injection Cessation among Injection Drug Users (IDUs)$51,728
R36 · FY2008 · DA · contact PI